oncology

Merck KGaA taps AI-focused biotech for new ADC pact worth $376M
Fierce Biotech
Tue, 06/4/24 - 11:33 am
Merck KGaA
Biolojic Design
drug discovery
antibody-drug conjugates
oncology
Clinical-stage cancer biotech Actuate latest to eye summer IPO
Fierce Biotech
Tue, 05/28/24 - 10:53 am
Actuate Therapeutics
IPOs
cancer
oncology
Where competition is heating up in pharma
Pharma Voice
Fri, 05/24/24 - 11:06 am
competition
oncology
immunology
COPD
RSV
ulcerative colitis
GSK
JNJ
Moderna Therapeutics
Boehringer outlines up to $33.6m for cancer asset from OSE Therapeutics
Clinical Trials Arena
Thu, 05/23/24 - 09:43 pm
Boehringer Ingelheim
OSE Immunotherapeutics
oncology
AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies
Fierce Biotech
Thu, 05/23/24 - 10:47 am
AstraZeneca
Harbour BioMed
Nona Biosciences
cancer
oncology
Too old for pediatric trials, too young for adult trials
Clinical Trials Arena
Mon, 05/13/24 - 11:10 am
clinical trials
adolescents
pediatric
oncology
Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?
BioSpace
Mon, 05/13/24 - 10:50 am
cancer
oncology
cancer vaccines
R&D
The Enhertu effect: Daiichi’s plan to build on the success of its crown jewel
Pharma Voice
Fri, 05/10/24 - 11:12 am
Daiichi Sankyo
Enhertu
oncology
Merck
AZ oncology chief says AI can help solve cancer’s ‘ZIP code lottery’ as health disparities persist
Pharma Voice
Wed, 05/8/24 - 11:25 am
AstraZeneca
oncology
artificial intelligence
R&D
How mRNA vaccines could be personalized cancer cures
Axios
Tue, 05/7/24 - 10:59 am
MRNA
vaccines
cancer
personalized medicine
oncology
IO Biotech
Merck
BioNTech
AstraZeneca Invests $140M in Cellectis, Secures 44% Stake in CAR-T Specialist
BioSpace
Mon, 05/6/24 - 11:41 am
AstraZeneca
Cellectis
CAR-T
oncology
allogeneic cells
A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach
BioSpace
Tue, 04/30/24 - 09:10 am
Takeda
oncology
colorectal cancer
Fruzaqla
Annette Montandon
Vaccines, next-gen approaches target the toughest cancers: AACR
BioSpace
Fri, 04/12/24 - 11:36 am
cancer
oncology
AACR
vaccines
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit
BioSpace
Wed, 04/10/24 - 05:44 pm
AACR
oncology
FDA
accelerated approvals
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
Merck KGaA signs $1.4B biobuck deal with Caris to expand ADC pipeline
Fierce Biotech
Thu, 04/4/24 - 11:17 am
Merck KGaA
oncology
antibody-drug conjugates
Caris Life Sciences
Teva, forging ahead with new strategy, inks biosimilar deal with Spain's mAbxience
Fierce Pharma
Thu, 04/4/24 - 11:16 am
Teva Pharmaceutical
Spain
mAbxience
oncology
biosimilars
Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology
BioSpace
Mon, 03/25/24 - 11:32 am
Merck
Keytruda
immunotherapy
oncology
cancer
Eliem cuts in on Tango, proposing acquisition after strategic review
Fierce Biotech
Tue, 03/19/24 - 11:51 am
Eliem Therapeutics
Tango Therapeutics
M&A
oncology

Pages